Abstract : A combination of cis-Dichlorodiammineplatinum (CDDP) and 5-fluorouracil (5-FU) may be used to treat gastric carcinoma and a combination of CDDP and 5'-deoxy-5-fluorouridine (5'-DFUR) is a safe and effective outpatient treatment for advanced gastric carcinoma.
Introduction
While the number of gastric carcinoma cases responding to downstaging chemotherapy with cis-dichlorodiammineplatinum (CDDP) and 5-FU analogues is increasing1-9), malignant endocrine tumors (carcinoid and endocrine cell carcinoma) rarely respond to this treatment 10,11) We treated a patient, whose advanced gastric cancer was unresectable because of liver metastasis, with CDDP and 5'-deoxy-5-fluorouridine (5'-DFUR).
This treatment eventually enabled resection of his primary lesion. Microscopic examination of the resected specimen was consistent with endocrine cell carcinoma. (Japanese Research Society for Gastric Cancer classification) 12 Hematoxylin Eosin staining showed medium-sized spindle-shaped carcinoma cells proliferating to form a solid tumor (Fig. 7a) . The N/C ratio was high. There was a marked number of mitotic figures and the carcinoma invaded vessels. Pseudorosette structures were seen (Fig. 7b ). There was a massive necrotic area in the tumor, possibly the effect of chemotherapy (Fig . 8) .
Argyrophilia was evident in tumor cells with Grimelius staining (Fig. 9 ), but FontanaMasson stain was negative. The tumor cells were negative for PAS stain. On immunological staining, carcinoma cells stained with chromogranin A (Fig. 10 ), but not with keratin, a- fetoprotein, CEA, neouron-specific enolase, serotonin, glucagon, somatostacin, nor gastrin. Thus, this case was diagnosed as endocrine cell carcinoma. The pathological stage was nl, ss, ly3, v3, OW (-), aw (-), stage 4. Since Preusser et al.1) first reported EAP therapy (Etoposide, Adriamycin, and CDDP) for advanced gastric carcinoma, CDDP has become the main treatment for advanced gastric cancer in Japan 2-4) . Combination chemotherapy with CDDP and 5-FU analogues has synergistic effects') without severe side effects. 5'-DFUR, a prodrug of 5-FU, is efficiently converted to 5-FU by pyrimidine nucleoside phosphorylase which has higher activity in tumor than in normal tissue. Niitani et al. ") reported that 4 days of 5'-DFUR administration followed by 3 days withdrawal are more effective and less toxic than daily administration. A combination of 5'-DFUR (4 days administration and 10 days withdrawal) and CDDP is effective and without side effects such as diarrhea, anorexia, renal dysfunction, and leukopenia making it suitable for outpatient care 6-8). Takemoto et al.9) reported a case of gastric cancer in which partial response (PR) was maintained for 30 weeks with outpatient treatment for almost the entire period (4 days administration, 10 days withdrawal).
Therefore a combination of 5'-DFUR and CDDP is suitable for long-term outpatient treatment.
Endocrine cell carcinoma is a special type of gastric malignancy formerly considered a carcinoid14). Carcinoid is now classified into essential carcinoid, which has a good prognosis, and endocrine cell carcinoma, which progresses rapidly and has a poor prognosis15 . There are reports of carcinoid responding to nitrogen mustard 16), cyclophosphamide + methotrexate 17 , 5-FUN streptozosin18). Some studies found radiotherapy ineffective for carcinoid19), but others found it effective19,2O) . Hayashi et a1.11) reported a case of carcinoid with metastatis to the liver that responded to a combination of CDDP, 5-FU, doxorubicin, and cyclophosphamide. Therefore we thought endocrine cell carcinoma might respond to a combination of CDDP and 5-FU analogues. We treated this case as a common type gastric carcinoma, because in the initial biopsy the histology was poorly differentiated adenocarcinoma.
The lesion decreased with chemotherapy and became resectable; histopathology was consistent with endocrine cell carcinoma. Although the patient died from a recurrence to the brain twenty months after surgery (3 years and 4 months after onset) he was treated as an outpatient throughout that period.
We conclude that combination chemotherapy of CDDP and 5'-DFUR may be useful in malignant endocrine tumor of the stomach.
